NEW YORK (GenomeWeb) – Researchers at Saarland University and the Comprehensive Biomarker Center in Germany announced today that they have successfully used blood-based biomarkers to differentiate between non-small cell lung cancer patients, COPD patients, and healthy controls.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.